Leah Kuntz

Improving physical activity levels and eating habits could help patients with schizophrenia.

In an ADAPT-2 study, a combination of injectable naltrexone and oral bupropion showed promise for methamphetamine users.

The RISE study results look promising.

Major psychiatry organizations condemn the actions and events of January 6th.

A new formulation of dexmedetomidine meets primary and secondary endpoints in recently completed study.

A new phase 3 trial recently started for the novel treatment troriluzole.

New developments in Alzheimer disease treatment and research.

The first and only transdermal patch for the treatment of adults with schizophrenia shows positive phase 3 trial results.

VistaGen Therapeutic’s grant application for PH10, an investigational therapeutic agent for the treatment of depression, has been approved.

Findings bring us closer to understanding schizophrenia that may enable clinicians to target symptoms.

Axsome Therapeutics released details from their COMET-SI trial for AXS-05, an oral investigational NMDA receptor.

Karuna Therapeutics shared exciting results from a Phase 2 trial on their lead agent.

Looking for holiday gifts that encourage mental well being?

A new study by The Trevor Project finds that welcoming environments can reduce suicide risk.

According to a recent study, certain product combinations of alcohol and cannabis may be less likely to cause negative consequences.

Let's talk about money...

Mutations in PCM1, a gene crucial to neuronal cilia function, have been connected with schizophrenia, according to a recent study.

The Lumipulse® G β-Amyloid Ratio in vitro diagnostic test was filed for 510(k) premarket clearance.

A new study associates a gene that facilitates neuron communication in the nervous system with memory loss.

Female emergency department patients with adverse childhood experiences were more likely to have substance use issues.

Sexual minorities with alcohol and tobacco addictions are at a higher risk for comorbid psychiatric disorders, bisexual women in particular.

Suicide attempts among pregnant or postpartum mothers have nearly tripled over the past decade.

How has the COVID-19 pandemic affected the way young adults use substances like vaping, alcohol, and marijuana?

Key leaders experienced in real-world clinical practice share on a range of topics.

Fluvoxamine was not intended as a COVID-19 medication, but a recent study suggests it may help prevent serious complications for patients with COVID-19.

Manufacturing issues stall progress with ALKS 3831, Alkermes’s promising new drug for the treatment of schizophrenia and bipolar I disorder.

New research underlies the need for addressing identity in young patients during early stages of psychosis.

A new prescription smartwatch app may improve sleep quality for those with nightmare disorders.

Recently published data suggests a promising new treatment for patients with obsessive-compulsive disorder.

Good news in the fight against Alzheimer disease, with major progress in new, innovative treatments.